Lipoprotein apheresis in the era of new lipid-lowering therapies.
- DOI
- 10.1093/eurheartj/ehag328
- Published
- 2026 May 19
- Container
- European heart journal
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1093/eurheartj/ehag328,
title = {Lipoprotein apheresis in the era of new lipid-lowering therapies.},
author = {Sbrana F and Dal Pino B and Schettler VJJ and Muso E and Harada-Shiba M and Di Mola M and Kagitani M and Pineda E and Selke N and Jenke S and Zimmermann T and Bernhardt W and Bigazzi F and Heigl F and Grützmacher P and Löhlein I and Klingel R and Corciulo C and Hohenstein B and Ramlow W and Vogt A and Ramunni A and Emdin M and Sampietro T and Julius U and Schlieper G and Stefanutti C and Moriarty PM},
year = {2026},
journal = {European heart journal},
doi = {10.1093/eurheartj/ehag328},
url = {https://doi.org/10.1093/eurheartj/ehag328}
}RIS
TY - JOUR TI - Lipoprotein apheresis in the era of new lipid-lowering therapies. AU - Sbrana F AU - Dal Pino B AU - Schettler VJJ AU - Muso E AU - Harada-Shiba M AU - Di Mola M AU - Kagitani M AU - Pineda E AU - Selke N AU - Jenke S AU - Zimmermann T AU - Bernhardt W AU - Bigazzi F AU - Heigl F AU - Grützmacher P AU - Löhlein I AU - Klingel R AU - Corciulo C AU - Hohenstein B AU - Ramlow W AU - Vogt A AU - Ramunni A AU - Emdin M AU - Sampietro T AU - Julius U AU - Schlieper G AU - Stefanutti C AU - Moriarty PM PY - 2026 JO - European heart journal DO - 10.1093/eurheartj/ehag328 UR - https://doi.org/10.1093/eurheartj/ehag328 ER -
APA
F, S., B, D. P., VJJ, S., E, M., M, H., M, D. M., M, K., E, P., N, S., S, J., T, Z., W, B., F, B., F, H., P, G., I, L., R, K., C, C., B, H., W, R., A, V., A, R., M, E., T, S., U, J., G, S., C, S., & PM, M. (2026). Lipoprotein apheresis in the era of new lipid-lowering therapies.. European heart journal. https://doi.org/10.1093/eurheartj/ehag328
Source records
- pubmed · retrieved 2026-09-26T00:58:55.196Z
- europe-pmc · retrieved 2026-09-26T00:58:55.204Z